EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:31275 - betamethasone acetate
| Formula | C24H31FO6 |
| Net Charge | 0 |
| Average Mass | 434.504 |
| Monoisotopic Mass | 434.21047 |
| SMILES | [H][C@@]12C[C@H](C)[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@@]21C |
| InChI | InChI=1S/C24H31FO6/c1-13-9-18-17-6-5-15-10-16(27)7-8-21(15,3)23(17,25)19(28)11-22(18,4)24(13,30)20(29)12-31-14(2)26/h7-8,10,13,17-19,28,30H,5-6,9,11-12H2,1-4H3/t13-,17-,18-,19-,21-,22-,23-,24-/m0/s1 |
| InChIKey | AKUJBENLRBOFTD-QZIXMDIESA-N |
| Roles Classification |
|---|
| Biological Role: | analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. |
| Applications: | dermatologic drug A drug used to treat or prevent skin disorders or for the routine care of skin. anti-anaemic agent A compound which increases either the number of red cells or the amount of haemoglobin in the blood. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. anti-inflammatory agent Any compound that has anti-inflammatory effects. anti-asthmatic agent Any compound that has anti-asthmatic effects. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| betamethasone acetate (CHEBI:31275) has functional parent betamethasone (CHEBI:3077) |
| betamethasone acetate (CHEBI:31275) has role analgesic (CHEBI:35480) |
| betamethasone acetate (CHEBI:31275) has role anti-anaemic agent (CHEBI:75835) |
| betamethasone acetate (CHEBI:31275) has role anti-asthmatic agent (CHEBI:65023) |
| betamethasone acetate (CHEBI:31275) has role anti-inflammatory agent (CHEBI:67079) |
| betamethasone acetate (CHEBI:31275) has role dermatologic drug (CHEBI:50177) |
| betamethasone acetate (CHEBI:31275) is a 11β-hydroxy steroid (CHEBI:35346) |
| betamethasone acetate (CHEBI:31275) is a 17α-hydroxy steroid (CHEBI:35342) |
| betamethasone acetate (CHEBI:31275) is a 20-oxo steroid (CHEBI:36885) |
| betamethasone acetate (CHEBI:31275) is a 3-oxo-Δ1,Δ4-steroid (CHEBI:77166) |
| betamethasone acetate (CHEBI:31275) is a acetate ester (CHEBI:47622) |
| betamethasone acetate (CHEBI:31275) is a fluorinated steroid (CHEBI:50830) |
| betamethasone acetate (CHEBI:31275) is a steroid ester (CHEBI:47880) |
| betamethasone acetate (CHEBI:31275) is a tertiary α-hydroxy ketone (CHEBI:139592) |
| IUPAC Name |
|---|
| 9-fluoro-11β,17-dihydroxy-16β-methyl-3,20-dioxopregna-1,4-dien-21-yl acetate |
| Synonyms | Source |
|---|---|
| 9-Fluoro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione 21-acetate | ChemIDplus |
| Betamethasone 21-acetate | ChEMBL |
| Betamethasone acetate | ChEMBL |
| NSC-759196 | ChEMBL |
| Brand Names | Source |
|---|---|
| Betamethasone acetate component of celestone soluspan | ChEMBL |
| Betamethasone acetate component of osurnia | ChEMBL |
| Citations |
|---|